Embla Medical hfOSSFF 92 Interest Coverage is 4.65 as of Mar. 2026, which is 42% below its 10-year median of 8.08. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.49. The stock has 2 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Embla Medical hf ranks worse than 72.22% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Embla Medical hf's
Operating Income
for the
three
months ended in Mar. 2026 was $22.6 Mil. Embla Medical hf's Interest Expense for the
three
months ended in Mar. 2026 was $-4.9 Mil.
Embla Medical hf's interest coverage for the quarter that ended in Mar. 2026 was 4.65.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Embla Medical hf's Interest Coverage or its related term are showing as below:
OSSFF'
s Interest Coverage Range Over the Past 10 Years
Min: 4.85 Med: 8.08 Max: 26.37
Current: 6.05
OSSFF's Interest Coverage is ranked worse than 72.22% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs OSSFF: 6.05
Embla Medical hf (OTCPK:OSSFF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Embla Medical hf Interest Coverage Related Terms
Embla Medical hf Interest Coverage Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
OSSFF vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Embla Medical hf's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OSSFF) has a Interest Coverage of 4.65 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Embla Medical hf and its competitors. This is 42% below median its historical median of 8.08. Over the past decade, Embla Medical hf's Interest Coverage has ranged from 4.85 to 26.37. According to the industry distribution chart, Embla Medical hf ranks #338 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is Embla Medical hf's Interest Coverage too high?
Embla Medical hf's current Interest Coverage of 4.65 is 42% below median its 10-year median of 8.08. Over the past 10 years, this metric has ranged from a low of 4.85 to a high of 26.37. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Embla Medical hf's value of 4.65 is 70.4% below this industry median. Based on the distribution chart, Embla Medical hf ranks #338 out of 468 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #338 out of 468 companies for Interest Coverage. This places Embla Medical hf in the lower half of its industry. The industry median Interest Coverage is 15.71. Embla Medical hf's value of 4.65 is 70.4% below this benchmark. Historically, Embla Medical hf's own Interest Coverage has ranged from 4.85 to 26.37 over the past decade. While the company's 10-year median is 8.08 vs. the industry median of 15.71, Embla Medical hf has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Interest Coverage of 4.65 is 70.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Interest Coverage is 4.65, which is 42% below median its own 10-year median of 8.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Interest Coverage of 4.65. The stock's GF Value™ is $5.49, compared to a current price of $4.15 — trading 24.4% below its estimated fair value. The current Interest Coverage is 4.65, which is 42% below median its 10-year median of 8.08 and 70.4% below the Medical Devices & Instruments industry median of 15.71. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Interest Coverage is 4.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 24.4% below its estimated GF Value™ of $5.49.
Key valuation signals for OSSFF:
Interest Coverage: 4.65 (42% below median its 10-year median of 8.08)
GF Value™: $5.49 vs. price of $4.15 (24.4% below fair value)
Industry Position: 70.4% below the Medical Devices & Instruments median (#338 of 468)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
